tirzepatide diabetic retinopathy eye disease / diabetic stages No Increased Retinopathy Risk Seen

Es importante entender que 2.5 mg es una dosis de inicio para mejorar la tolerabilidad, no una dosis teraputica para control glucmico ptimo

Patients taking semaglutide frequently experience reduced hunger, earlier satiety, fewer high-calorie cravings, and increased energy, along with improvements in critical markers like blood pressure and cholesterol

Monitoring fasting glucose and potentially hemoglobin A1C ensures this remains manageable

Nobody really talks about how confusing food gets when you first start a GLP-1 like Ozempic, Wegovy, or Zepbound

Start at 0.5 mg and review the getting started with peptides guide for fundamentals